Serena Ruggieri

Rome, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 110 publications

Rethinking prognosis in multiple sclerosis: a multiaxial perspective.

Rethinking prognosis in multiple sclerosis: a multiaxial perspective.

Journal: Nature reviews. Neurology

Published: April 13, 2026

Predictors of short-term, relapse-independent progression in multiple sclerosis: A machine learning approach based on clinical data and conventional MRI-derived features.

Predictors of short-term, relapse-independent progression in multiple sclerosis: A machine learning approach based on clinical data and conventional MRI-derived features.

Journal: Journal of the neurological sciences

Published: December 03, 2025

Comparative Effectiveness of Cladribine and S1P Receptor Modulators in Treatment-Naive Relapsing-Remitting MS.

Comparative Effectiveness of Cladribine and S1P Receptor Modulators in Treatment-Naive Relapsing-Remitting MS.

Journal: JAMA network open

Published: November 03, 2025

How premorbid structural reserve affects disability accrual in multiple sclerosis.

How premorbid structural reserve affects disability accrual in multiple sclerosis.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Published: October 08, 2025

Sex-Related Differences in Lifestyle Factors Affecting Multiple Sclerosis Susceptibility and Disease Progression.

Sex-Related Differences in Lifestyle Factors Affecting Multiple Sclerosis Susceptibility and Disease Progression.

Journal: Brain sciences

Published: September 17, 2025

Deep Learning Modeling to Differentiate Multiple Sclerosis From MOG Antibody-Associated Disease.

Deep Learning Modeling to Differentiate Multiple Sclerosis From MOG Antibody-Associated Disease.

Journal: Neurology

Published: September 04, 2025

Minimal association between Th1-specific responses to COVID-19 vaccines and SARS-CoV-2 breakthrough infections in multiple sclerosis patients receiving disease-modifying therapies.

Minimal association between Th1-specific responses to COVID-19 vaccines and SARS-CoV-2 breakthrough infections in multiple sclerosis patients receiving disease-modifying therapies.

Journal: Frontiers in immunology

Published: August 08, 2025

Characterization of QuantiFERON-TB-Plus Results in Patients with Tuberculosis Infection and Multiple Sclerosis.

Characterization of QuantiFERON-TB-Plus Results in Patients with Tuberculosis Infection and Multiple Sclerosis.

Journal: Neurology international

Published: June 24, 2025

Home-based EXergames To impRovE cognitive function in MUltiple Sclerosis (EXTREMUS).

Home-based EXergames To impRovE cognitive function in MUltiple Sclerosis (EXTREMUS).

Journal: Journal of neurology, neurosurgery, and psychiatry

Published: April 30, 2025

Brain bright spotty lesions and leukodystrophy-like patterns in NMOSD relapse.

Brain bright spotty lesions and leukodystrophy-like patterns in NMOSD relapse.

Journal: Multiple sclerosis and related disorders

Published: April 14, 2025

Epilepsy in MS and its association with cognitive and psychological burden.

Epilepsy in MS and its association with cognitive and psychological burden.

Journal: Multiple sclerosis journal - experimental, translational and clinical

Published: March 18, 2025

Comparative effectiveness, safety and persistence of ocrelizumab versus natalizumab in multiple sclerosis: A real-world, multi-center, propensity score-matched study.

Comparative effectiveness, safety and persistence of ocrelizumab versus natalizumab in multiple sclerosis: A real-world, multi-center, propensity score-matched study.

Journal: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics

Published: November 26, 2024

Showing 1-12 of 110

Last Updated: 09/26/2026